A randomised, assessor-blind, controlled phase 3 non-inferiority trial assessing the efficacy and safety of individualised follitropin delta dosing regimen in Japanese IVF/ICSI patients

被引：0
|
作者：
Ishihara, O. [1 ]
Kitamura, M. [2 ]
Arce, J. C. [3 ]
机构：
[1] Saitama Med Univ, Dept Obstet & Gynaecol, Moroyama, Saitama, Japan
[2] Ferring Pharmaceut, Dev, Tokyo, Japan
[3] Ferring Pharmaceut, Reprod Med & Maternal Hlth, Copenhagen, Denmark
来源：
HUMAN REPRODUCTION | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-566
引用
收藏
页码：I397 / I397
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of follitropin delta in an individualised dosing regimen: a randomised, assessor-blind, controlled phase 3 trial in IVF/ICSI patients (ESTHER-1)
    Andersen, A. Nyboe
    Arce, J. C.
    [J]. HUMAN REPRODUCTION, 2016, 31 : 315 - 315
  • [2] A randomised, controlled, assessor-blind trial assessing clinical outcomes of individualised dosing with follitropin delta in Asian IVF/ICSI patients
    Qiao, J.
    Zhang, Y.
    Liang, X.
    Ho, T.
    Huang, H. Y.
    Kim, S. H.
    Goethberg, M.
    Mannaerts, B.
    Arce, J. C.
    [J]. HUMAN REPRODUCTION, 2021, 36 : 41 - 42
  • [3] Follitropin delta in repeated ovarian stimulation for IVF: a controlled, assessor-blind Phase 3 safety trial
    Bosch, Ernesto
    Havelock, Jon
    Sanchez Martina, Fernando
    Rasmussen, Birgitte Buur
    Klein, Bjarke Mirner
    Mannaerts, Bernadette
    Arce, Joan-Cartes
    Lindberg, Sofia Rondin
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2019, 38 (02) : 195 - 205
  • [4] A randomised, assessor-blind, AMH-stratified, dose-response trial in Japanese IVF/ICSI patients undergoing controlled ovarian stimulation with follitropin delta
    Ishihara, O.
    Arce, J. C.
    [J]. HUMAN REPRODUCTION, 2017, 32 : 444 - 444
  • [5] A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian IVF/ICSI patients
    Qiao, Jie
    Zhang, Yunshan
    Liang, Xiaoyan
    Ho, Tuong
    Huang, Hong-Yuan
    Kim, Sung-Hoon
    Goethberg, Marie
    Mannaerts, Bernadette
    Arce, Joan-Carles
    [J]. HUMAN REPRODUCTION, 2021, 36 (09) : 2452 - 2462
  • [6] SIMILAR OVARIAN RESPONSE WITH INDIVIDUALIZED FOLLITROPIN DELTA DOSING REGIMEN IN JAPANESE AND NON-JAPANESE IVF/ICSI PATIENTS.
    Ishihara, Osamu
    Andersen, Anders Nyboe
    Nelson, Scott M.
    Arce, Joan-Carles
    [J]. FERTILITY AND STERILITY, 2020, 114 (03) : E286 - E287
  • [7] Individualized follitropin delta dosing reduces OHSS risk in Japanese IVF/ICSI patients: a randomized controlled trial
    Ishihara, Osamu
    Arce, Joan-Cartes
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2021, 42 (05) : 909 - 918
  • [8] BEYOND: a randomised controlled trial comparing efficacy and safety of individualised follitropin delta dosing in GnRH agonist versus antagonist protocols for first ovarian stimulation cycle
    Sordal, T.
    Ekerhovd, E.
    Cohlen, B.
    Schenk, M.
    Larsson, P.
    Lobo, R.
    Pinton, P.
    Pinborg, A.
    [J]. HUMAN REPRODUCTION, 2023, 38
  • [9] Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial
    Baulac, Michel
    Rosenow, Felix
    Toledo, Manuel
    Terada, Kiyohito
    Li, Ting
    De Backer, Marc
    Werhahn, Konrad
    Brock, Melissa
    [J]. LANCET NEUROLOGY, 2017, 16 (01): : 43 - 54
  • [10] Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial
    Kenemans, Peter
    Bundred, Nigel J.
    Foidart, Jean-Michel
    Kubista, Ernst
    von Schoultz, Bo
    Sismondi, Piero
    Vassilopoulou-Sellin, Rena
    Yip, Cheng Har
    Egberts, Jon
    Mol-Arts, Mirjam
    Mulder, Roel
    van Os, Steve
    Beckmann, Matthias W.
    [J]. LANCET ONCOLOGY, 2009, 10 (02): : 135 - 146
12345